Package Leaflet: Information for the User
Latanest 50 micrograms/ml eye drops, solution
Latanoprost
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the package leaflet
Latanest belongs to a group of medicines known as prostaglandin analogues. It works by increasing the natural outflow of fluid from the eye into the bloodstream.
Latanest is used to treat conditions known as open-angle glaucoma and ocular hypertensionin adults. Both of these conditions are linked to an increase in pressure within the eye, which can lead to problems with your sight.
Latanest is also used to treat increased pressure in the eye and glaucoma in babies and children of all ages.
Latanest can be used in adult men and women (including the elderly) and in children from birth to 18 years of age. Latanest has not been studied in premature infants (less than 36 weeks gestation).
Latanest eye drops, solution is a sterile solution that does not contain preservatives.
Do not use Latanest:
Warnings and precautions
If you think any of the following apply to you or your child, tell your doctor, or the doctor treating your child, or your pharmacist before using Latanest:
Other medicines and Latanest
Latanest may have interactions with other medicines. Tell your doctor, or the doctor treating your child, or your pharmacist if you or your child are using or have recently used other medicines (or eye drops), including those obtained without a prescription.
Pregnancy and breast-feeding
Pregnancy
Do not use Latanest if you are pregnant. If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.
Breast-feeding
Do not use Latanest if you are breast-feeding.
Driving and using machines
When using Latanest, you may experience blurred vision for a short time. If this happens, do not drive or use tools or machines until your vision is clear again.
Latanest containsmacrogolglycerol hydroxystearate 40
This medicine contains macrogolglycerol hydroxystearate 40, which may cause skin reactions.
Latanest containsphosphate buffer
This medicine contains 6.35 mg of phosphates in each ml of solution.
If you have severe damage to the clear layer on the front of your eye (cornea), treatment with phosphates, in very rare cases, may cause blurred vision due to calcium deposits.
Follow exactly the instructions given to you by your doctor, or the doctor treating your child. Ask your doctor, or the doctor treating your child, or your pharmacist if you are unsure.
The recommended dose for adults (including the elderly) and children is one drop once a day in the affected eye(s). The best time to instil the product is in the evening.
Do not use Latanest more than once a day, because the effectiveness of the treatment may decrease if it is administered more frequently.
Use Latanest as instructed by your doctor or the doctor treating your child until they tell you to stop.
Contact lens wearers
If you or your child wear contact lenses, remove them before using Latanest. Wait 15 minutes after applying Latanest before putting the contact lenses back in.
Instructions for use
1a 1b |
|
|
|
3 |
|
4 |
|
5 |
|
2.5 ml: 5 ml: |
If you use Latanest with other eye drops
Wait at least 5 minutes between using Latanest and other eye drops.
If you use more Latanest than you should
If you have applied more drops in the eye than you should, you may feel a mild irritation in the eye and your eyes may become red and watery. This should go away, but if you are worried, contact your doctor or the doctor treating your child.
In case of accidental ingestion by you or your child, contact your doctor or pharmacist as soon as possible, or call the Toxicology Information Service, phone: 91 562 04 20.
If you forget to use Latanest
Continue with the next dose as usual. Do not apply an extra drop in the eye to make up for the missed dose. If you are unsure, ask your doctor or pharmacist.
If you stop using Latanest
If you want to stop using Latanest, talk to your doctor or the doctor treating your child.
If you have any questions about using this product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The following side effects have been seen with the use of eye drops containing the active substance latanoprost:
Very common side effects(may affect more than 1 in 10 people):
Common side effects(may affect up to 1 in 10 people):
Uncommon side effects(may affect up to 1 in 100 people):
Rare side effects(may affect up to 1 in 1,000 people):
Very rare side effects(may affect up to 1 in 10,000 people):
Side effects seen in children more frequently than in adults are runny nose, itchy nose and fever.
If you have severe damage to the clear layer on the front of your eye (cornea), treatment with phosphates, in very rare cases, may cause blurred vision due to calcium deposits.
Reporting of side effects:
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and bottle after EXP. The expiry date is the last day of the month shown.
Store below 25°C.
After first opening, this medicine does not require any special storage conditions.
2.5 ml:
You must discard the bottle after 4 weeks of first opening, to prevent infections. Write the date you opened the bottle on the carton and on the bottle in the space provided.
5 ml:
You must discard the bottle after 8 weeks of first opening, to prevent infections. Write the date you opened the bottle on the carton and on the bottle in the space provided.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
What Latanest contains
Appearance and packaging
2.5 ml:
Latanest eye drops, solution is a clear, colorless solution, corresponding to approximately 80 drops of solution, free from visible particles.
It is available in cartons containing a 5 ml multidose bottle (HDPE) with a pump (PP, HDPE, LDPE) and a green pressure cylinder and cap (HDPE).
5 ml:
Latanest eye drops, solution is a clear, colorless solution, corresponding to approximately 160 drops of solution, free from visible particles.
It is available in cartons containing a 5 ml multidose bottle (HDPE) with a pump (PP, HDPE, LDPE) and a green pressure cylinder and cap (HDPE).
Pack sizes:
Carton with 1 or 3 bottles of 2.5 ml solution or 1 or 3 bottles of 5 ml solution.
Not all pack sizes may be marketed.
Marketing authorisation holder and manufacturer
Marketing authorisation holder
Esteve Pharmaceuticals, S.A.
Passeig de la Zona Franca, 109
08038 Barcelona
Manufacturer
Lomapharm GmbH
Langes Feld 5
31860 Emmerthal
Germany
Pharmathen S.A.
Dervenakion Str. 6
Pallini 15351
Attiki
Greece
This medicine is authorised in the Member States of the European Economic Area under the following names:
Denmark Tanafra
Cyprus Tanafra
France LATAZED 50 microgrammes/mL, collyre en solution
Germany Tanafra 50 Mikrogramm/ml Augentropfen, Lösung
Greece Tanafra
Italy LASTAFRY
Spain Latanest 50 micrograms/ml eye drops, solution
Date of last revision of this leaflet: September 2024
Detailed and up-to-date information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of LATANEST 50 micrograms/ml eye drops solution in October, 2025 is around 13 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.